Meta-analysis of GWAS results for six collections (top panel) and replication datasets available from prior study (bottom panel) are listed. For each collection, we list the source of controls, geographic origin, autoantibody status of cases, numbers of cases and controls, genotyping platform (GWAS collection microarray platform and replication and validation/prediction collection direct-genotyping technology) and the strategy used to correct for case-control population stratification. RF, rheumatoid factor; CCP, cyclic citrullinated peptide; PC, principal components. For each of the 13 SNPs and for each patient collection we list a z-score suggesting the strength of association for that SNP. A positive z-score suggests that the direction of association is consistent with that of the previously published meta-analysis. z>1.63 corresponds to p<0.05. If genotype data was not available due to failure to pass quality control criteria, we have denoted it as NA.
